SALIX PHARMACEUTICALS LTD Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
SALIX PHARMACEUTICALS LTD had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $17.70 per share as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2015-03-02
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $17.70.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $17.66.
- 2012-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $17.47.
- 2011-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $13.55.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2014-12-31 | $17.70 10-K · filed 2015-03-02 |
| 2013-12-31 | $17.66 10-K · filed 2015-03-02 |
| 2012-12-31 | $17.47 10-K · filed 2013-03-01 |
| 2011-12-31 | $13.55 10-K · filed 2012-02-28 |